Ultra-small RNAs as TLR3 antagonists - 1548
- Technology Benefits
- Inventionincludes methods for the development of a therapeutic for diseases anddisorders stemming from the activation of TLR3
- Detailed Technology Description
- None
- *Abstract
-
None
- Country/Region
- USA

For more information, please click Here